Ultra-high-performance liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and sphingolipids in drug resistance tumor cells

Journal of Chromatography A

Volumn 1381, Issue , 2015, Pages 140-148

  Li, Lin ^a,b   Wang, Linlin ^a   Shangguan, Dihua ^a   Wei, Yanbo ^a,b   Han, Juanjuan ^a   Xiong, Shaoxiang ^a   Zhao, Zhenwen ^a  

^a INSTITUTE OF CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Glycerophospholipids; MCF 7; MCF 7R; Sphingolipids; UHPLC ESI MS MS

Indexed keywords

CELLS; CYTOLOGY; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION SOURCES; LIQUIDS; MASS SPECTROMETRY; TUMORS;

ESI-MS/MS; GLYCEROPHOSPHOLIPIDS; MCF-7; MCF-7R; SPHINGOLIPIDS;

LIPIDS;

CARBON 13; CEREBROSIDE; GLYCEROPHOSPHOLIPID; SPHINGOLIPID; SULFATIDE; ANTINEOPLASTIC AGENT;

ACCURACY; ARTICLE; CANCER RESISTANCE; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; LIPID ANALYSIS; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; TEMPERATURE DEPENDENCE; TEMPERATURE SENSITIVITY; TUMOR CELL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS; DRUG RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MCF 7 CELL LINE; PROCEDURES;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, NEOPLASM; GLYCEROPHOSPHOLIPIDS; HUMANS; MCF-7 CELLS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOLIPIDS; TANDEM MASS SPECTROMETRY;

EID: 84922821713     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.01.013     Document Type: Article

References (26)

1. Hirsch H.A., Iliopoulos D., Joshi A., Zhang Y., Jaeger S.A., Bulyk M., Tsichlis P.N., Liu S.X., Struhl K. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010, 17:348-361.
2. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9:139-150.
3. Quehenberger O., Dennis E.A. The human plasma lipidome. N. Engl. J. Med. 2011, 365:1812-1823.
4. Chaurio R.A., Janko C., Muñoz L.E., Frey B., Herrmann M., Gaip U.S. Phospholipids: key players in apoptosis and immune regulation. Molecules 2009, 14:4892-4914.
5. Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9:112-124.
6. Fahy E., Subramaniam S., Murphy R.C., Nishijima M., Raetz C.R.H., Shimizu T., Spener F., Meer G., Wakelam M.J.O., Dennis E.A. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50:S9-S14.
7. Bligh E.G., Dyer W.J. A rapid method for total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
8. Chen S.L., Hoene M., Li J., Li Y.J., Zhao X.J., Häring H.U., Schleicher E.D., Weigert C., Xu G.W., Lehmann R. Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J. Chromatogr. A 2013, 1298:9-16.
9. Zhao Z.W., Xu Y. An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J. Lipid Res. 2010, 51:652-659.
10. Li F., Qin X.Z., Chen H.Q., Qiu L., Guo Y.M., Liu H., Chen G.Q., Song G.G., Wang X.D., Li F.J., Guo S., Wang B.H., Li Z.L. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun. Mass Spectrom. 2013, 27:24-34.
11. Han X.L., Rozen S., Boyle S.H., Hellegers C., Cheng H., Burke J.R., Welsh-Bohmer K.A., Doraiswamy P.M., Kaddurah-Daouk R. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS ONE 2011, 6:e21643.
12. Zhao Z.W., Xu Y. Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. J. Chromatogr. B 2009, 877:3739-3742.
13. Hummel J., Segu S., Li Y., Irgang S., Jueppner J., Giavalisco P. Ultra performance liquid chromatography and high resolution mass spectrometry for the analysis of plant lipids. Front. Plant Sci. 2011, 2. 10.3389/fpls.2011.00054.
14. Cífková E., Holćapek M., Lísa M., Ovćaćíková M., Lyćka A., Lynen F., Sandra P. Nontargeted quantitation of lipid classes using hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry with single internal standard and response factor approach. Anal. Chem. 2012, 84:10064-10070.
15. Li J., Hu C.X., Zhao X.J., Dai W.D., Chen S.L., Lu X., Xu G.W. Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: method development and application in hepatocellular carcinoma. J. Chromatogr. A 2013, 1320:103-110.
16. Shaner R.L., Allegood J.C., Park H., Wang E., Kelly S., Haynes C.A., Sullards M.C., Merrill A.H. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 2009, 50:1692-1707.
17. Löfgren L., Stahlman M., Forsberg G.B., Saarinen S., Nilsson R., Hansson G.I. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J. Lipid Res. 2012, 53:1690-1700.
18. Morishige J., Urikura M., Takagi H., Hirano K., Koike T., Tanaka T., Satouchi K. A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. Rapid Commun. Mass Spectrom. 2010, 24:1075-1084.
19. Ruiz J., Antequera T., Andres A.I., Petron M.J., Muriel E. Improvement of a solid phase extraction method for analysis of lipid fractions in muscle foods. Anal. Chim. Acta 2004, 520:201-205.
20. Reis A., Rudnitskaya A., Blackburn G.J., Mohd-Fauzi N., Pitt A.R., Spickett C.M. A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL. J. Lipid Res. 2013, 54:1812-1824.
21. Koul O., Singh I., Jungalwala F.B. Synthesis and transport of cerebrosides and sulfatides in rat brain during development. J. Neurochem. 1988, 50:580-588.
22. Dennis E.A., Alex Brown H., Deems R.A., Glass C.K., Merrill A.H., Murphy R.C., Raetz C.R.H., Shaw W., Subramaniam S., Russell D.W., VanNieuwenhze M.S., White S.H., Witztum J.L., Wooley J. The lipid maps approach to lipidomics. Functional Lipidomics 2005, 22. CRC Press, Boca Raton. F. Li, G.D. Prestwich (Eds.).
23. Struckhoff A.P., Patel B., Beckman B.S. Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment. Int. J. Oncol. 2010, 37:21-30.
24. Liu Y.Y., Patwardhan G.A., Bhinge K., Gupta V., Gu X., Jazwinsk S.M. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Cancer Res. 2011, 71:2276-2285.
25. Murph M.M., Hurst-Kennedy J., Newton V., Brindley D.N., Radhakrishna H. Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells. Mol. Cancer Res. 2007, 5:1201-1211.
26. Monet M., Gkika D., Lehen'kyi V., Pourtier A., Vanden Abeele F., Bidaux G., Juvin V., Rassendren F., Humez S., Prevarsakaya N. Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim. Biophys. Acta 2009, 1793:528-539.